Cormorant Asset Management’s Neumora Therapeutics NMRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-92,293	Closed	-$1.57M	–	60
2023 Q4	$1.57M	Hold	92,293	–	–	0.08%	47
2023 Q3	$1.3M	Buy	+92,293	New	+$1.3M	0.08%	46